Protein Therapeutics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Protein Therapeutics Market to 2027 - Global Analysis and Forecasts By Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone), Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) End user (Pharmaceutical companies, Healthcare service providers, Research Organizations & Academic Research Institutes) and Geography

Report Code: TIPRE00002856 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Protein therapeutics delivers proteins to the body in precise amounts (as required by the patient), to treat various medical conditions like diabetes, anemia, chronic renal failure or remake structures. Therapeutic proteins are fast-acting and potent medicines and have proved very successful in the treatment of a wide range of diseases. With growing understanding of the molecular mechanisms of disease, there will continue to be opportunities to develop protein therapeutics. The protein therapeutics field has developed significantly from 1982, since the introduction of the first human insulin protein derived from recombinant DNA. Proteins have several advantages over small molecule drugs that currently dominate the pharmaceutical market.

Increasing focus on development of protein therapeutic products, continuous innovations in recombinant protein drugs, and growing antibody based drugs have led to increased research on protein engineering. Therapeutic proteins and peptides have also been identified as great potential for the treatment of various diseases like cancers, neurodegenerative disease and others. However, physiochemical instability of protein and immunogenicity concerns are likely to restrain the global Protein Therapeutics market over the forecast period.

The "Global Protein Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, application, end user and geography. The global Protein Therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Protein Therapeutics market players and offers key trends and opportunities in the market.

The global protein therapeutics market is segmented on the basis of product, application, end user. Based on product, the market is segmented into monoclonal antibodies, insulin, fusion protein, erythropoietin, interferon, human growth hormone, and follicle stimulating hormone. The protein therapeutics market by application is categorized into metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others. Based on end user, the protein therapeutics market is classified into pharmaceutical companies, healthcare service providers, research organizations & academic research institutes.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global protein therapeutics market based product, application, and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Protein Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America held the dominant share in protein therapeutics market in 2017. The major share is attributed to technological advancements, favorable reimbursement policies, development of novel products and improved standard of living have led to increased life expectancy, contributing to rise in geriatric population. These factors are boosting growth of protein therapeutics in this region.
The Asia-Pacific region is expected to exhibit highest CAGR during the forecast period due to high prevalence of chronic diseases like diabetes. Also, the growing medical tourism industry in Asia Pacific region is also a major factor that is anticipated to propel the market demand for protein therapeutics market during the forecast period. Moreover, factors like growing demand for advanced treatment options, emerging economies like China, India and Japan, and increasing per capita income are anticipated to create growth avenues for the market players in Asia Pacific over the forecast period.

The report analyzes factors affecting Protein Therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Protein Therapeutics market in these regions.

The report also includes the profiles of key Protein Therapeutics companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the Protein Therapeutics market include Novo Nordisk A/S, Janssen Global Services, LLC (Johnson & Johnson Services, Inc.), Amgen Inc., AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Kyowa Hakko Kirin Co., Ltd., Pfizer Inc., and F. Hoffmann-La Roche Ltd among others.

.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Protein Therapeutics Market- By Product
1.3.2. Protein Therapeutics Market- By Application
1.3.3. Protein Therapeutics Market- By End User
1.3.4. Protein Therapeutics Market- By Region
1.3.4.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROTEIN THERAPEUTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. PROTEIN THERAPEUTICS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROTEIN THERAPEUTICS MARKET- GLOBAL ANALYSIS
6.1. PROTEIN THERAPEUTICS MARKET - GLOBAL MARKET OVERVIEW
6.2. PROTEIN THERAPEUTICS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. PROTEIN THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODIES MARKET
7.3.1. Overview
7.3.2. Monoclonal Antibodies Market Forecast And Analysis (US$ Mn)
7.4. INSULIN MARKET
7.4.1. Overview
7.4.2. Insulin Market Forecast and Analysis (US$ Mn)
7.5. FUSION PROTEIN MARKET
7.5.1. Overview
7.5.2. Fusion Protein Market Forecast and Analysis (US$ Mn)
7.6. ERYTHROPOIETIN MARKET
7.6.1. Overview
7.6.2. Erythropoietin Market Forecast and Analysis (US$ Mn)
7.7. INTERFERON MARKET
7.7.1. Overview
7.7.2. Interferon Market Forecast and Analysis (US$ Mn)
7.8. HUMAN GROWTH HORMONE MARKET
7.8.1. Overview
7.8.2. Human Growth Hormone Market Forecast and Analysis (US$ Mn)
7.9. FOLLICLE STIMULATING HORMONE MARKET
7.9.1. Overview
7.9.2. Follicle Stimulating Hormone Market Forecast and Analysis (US$ Mn)



8. PROTEIN THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. METABOLIC DISORDERS MARKET
8.3.1. Overview
8.3.2. Metabolic DisordersMarket Forecast and Analysis (US$ Mn)
8.4. IMMUNOLOGIC DISORDERS MARKET
8.4.1. Overview
8.4.2. Immunologic Disorders Market Forecast and Analysis (US$ Mn)
8.5. HEMATOLOGICAL DISORDERSMARKET
8.5.1. Overview
8.5.2. Hematological Disorders Market Forecast and Analysis (US$ Mn)
8.6. CANCER MARKET
8.6.1. Overview
8.6.2. Cancer Market Forecast and Analysis (US$ Mn)
8.7. HORMONAL DISORDERS MARKET
8.7.1. Overview
8.7.2. Hormonal Disorders Market Forecast and Analysis (US$ Mn)
8.8. GENETIC DISORDERS MARKET
8.8.1. Overview
8.8.2. Genetic Disorders Market Forecast and Analysis (US$ Mn)
8.9. OTHERS MARKET
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis (US$ Mn)

9. PROTEIN THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL COMPANIES MARKET
9.3.1. Overview
9.3.2. Pharmaceutical companies Market Forecast and Analysis (US$ Mn)
9.4. RESEARCH ORGANIZATIONS & ACADEMIC RESEARCH INSTITUTES MARKET
9.4.1. Overview
9.4.2. Research Organizations Market Forecast and Analysis (US$ Mn)
9.5. HEALTHCARE SERVICE PROVIDERS MARKET
9.5.1. Overview
9.5.2. Healthcare service providers Market Forecast and Analysis (US$ Mn)

10. PROTEIN THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA PROTEIN THERAPEUTICS MARKET
10.1.1. North America Protein Therapeutics Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.3. North America Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.4. North America Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.5. North America Protein Therapeutics Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.6.2. US Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.6.3. US Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.7.2. Canada Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.7.3. Canada Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.8.2. Mexico Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.8.3. Mexico Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2. EUROPE PROTEIN THERAPEUTICS MARKET
10.2.1. Europe Protein Therapeutics Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.3. Europe Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.4. Europe Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.5. Europe Protein Therapeutics Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Protein Therapeutics Market Forecasts and Analysis - By Product(US$ Mn)
10.2.6.2. UK Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.6.3. UK Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Germany Protein Therapeutics Market Forecasts and Analysis - By Product(US$ Mn)
10.2.7.2. Germany Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.7.3. Germany Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Protein Therapeutics Market Forecasts and Analysis - By Product(US$ Mn)
10.2.8.2. France Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.8.3. France Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3. ASIA PACIFIC PROTEIN THERAPEUTICS MARKET
10.3.1. Asia Pacific Protein Therapeutics Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.3. Asia Pacific Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.4. Asia Pacific Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.5. Asia Pacific Protein Therapeutics Market Forecasts and Analysis - By Country
10.3.6. Japan Market Overview
10.3.6.1. Japan Protein Therapeutics Market Forecasts and Analysis - By Product(US$ Mn)
10.3.6.2. Japan Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.6.3. Japan Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.7. China Market Overview
10.3.7.1. China Protein Therapeutics Market Forecasts and Analysis - By Product(US$ Mn)
10.3.7.2. China Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.7.3. China Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.8. India Market Overview
10.3.8.1. India Protein Therapeutics Market Forecasts and Analysis - By Product(US$ Mn)
10.3.8.2. India Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.8.3. India Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.4. MIDDLE EAST & AFRICA (MEA) PROTEIN THERAPEUTICS MARKET
10.4.1. Middle East & Africa (MEA) Protein Therapeutics Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East & Africa (MEA) Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.3. Middle East & Africa (MEA) Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.4. Middle East & Africa (MEA) Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.5. Middle East & Africa (MEA) Protein Therapeutics Market Forecasts and Analysis - By Country
10.4.6. South Africa Market Overview
10.4.6.1. South Africa Protein Therapeutics Market Forecasts and Analysis - By Product(US$ Mn)
10.4.6.2. South Africa Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.6.3. South Africa Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.7.2. Saudi Arabia Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.7.3. Saudi Arabia Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.8. UAE Market Overview
10.4.8.1. UAE Protein Therapeutics Market Forecasts and Analysis - By Product(US$ Mn)
10.4.8.2. UAE Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.8.3. UAE Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA PROTEIN THERAPEUTICS MARKET
10.5.1. South And Central America Protein Therapeutics Market Forecasts and Analysis (US$ Mn)
10.5.2. South And Central America Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.5.3. South And Central America Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.4. South And Central America Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)
10.5.5. South And Central America Protein Therapeutics Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Protein Therapeutics Market Forecasts and Analysis - By Product (US$ Mn)
10.5.6.2. Brazil Protein Therapeutics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.6.3. Brazil Protein Therapeutics Market Forecasts and Analysis - By End User (US$ Mn)

11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions

12. PROTEIN THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. NOVO NORDISK A/S
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JANSSEN GLOBAL SERVICES, LLC (JOHNSON & JOHNSON SERVICES, INC.)
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AMGEN INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAXTER
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. KYOWA HAKKO KIRIN CO., LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. F. HOFFMANN-LA ROCHE LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novo Nordisk A/S
2. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
3. Amgen Inc.
4. AstraZeneca
5. Baxter
6. Boehringer Ingelheim International GmbH
7. Teva Pharmaceutical Industries Ltd.
8. Kyowa Hakko Kirin Co., Ltd.
9. Pfizer Inc.
10. F. Hoffmann-La Roche Ltd